Evoke plc (LON:EVOK – Get Free Report) shares were down 10% during trading on Thursday . The stock traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). Approximately 65,066,164 shares changed hands during trading, an increase of 1,994% from the average daily volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).
Wall Street Analysts Forecast Growth
Several brokerages recently weighed in on EVOK. Berenberg Bank dropped their target price on Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating on the stock in a research note on Wednesday, December 4th. Jefferies Financial Group reissued a “buy” rating and issued a GBX 140 ($1.81) price target on shares of Evoke in a report on Monday, December 16th.
Get Our Latest Research Report on EVOK
Evoke Price Performance
Evoke (LON:EVOK – Get Free Report) last released its earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share (EPS) for the quarter. Evoke had a negative net margin of 8.50% and a negative return on equity of 517.98%. Analysts expect that Evoke plc will post 12.7648305 earnings per share for the current year.
Insider Transactions at Evoke
In other news, insider Andrea Gisle Joosen bought 14,572 shares of the company’s stock in a transaction that occurred on Tuesday, January 28th. The shares were purchased at an average price of GBX 70 ($0.91) per share, for a total transaction of £10,200.40 ($13,202.69). Company insiders own 27.00% of the company’s stock.
Evoke Company Profile
Read More
- Five stocks we like better than Evoke
- Why is the Ex-Dividend Date Significant to Investors?
- MarketBeat Week in Review – 03/24 – 03/28
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- The Basics of Support and Resistance
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.